Abnormal calcium homeostasis in peripheral neuropathies.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 2834846)

Published in Cell Calcium on December 24, 2009

Authors

Paul Fernyhough1, Nigel A Calcutt

Author Affiliations

1: Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada R3E0T6. paulfernyhough@yahoo.com

Articles citing this

Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease. Pharmacol Rev (2011) 1.38

Endoplasmic-reticulum calcium depletion and disease. Cold Spring Harb Perspect Biol (2011) 1.31

Concepts for regulation of axon integrity by enwrapping glia. Front Cell Neurosci (2013) 0.91

Axonal neuropathy-associated TRPV4 regulates neurotrophic factor-derived axonal growth. J Biol Chem (2011) 0.87

The upregulation of α2δ-1 subunit modulates activity-dependent Ca2+ signals in sensory neurons. J Neurosci (2015) 0.85

Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment. FASEB J (2012) 0.84

Painful nerve injury decreases sarco-endoplasmic reticulum Ca²⁺-ATPase activity in axotomized sensory neurons. Neuroscience (2012) 0.83

Genetic inactivation and pharmacological blockade of sigma-1 receptors prevent paclitaxel-induced sensory-nerve mitochondrial abnormalities and neuropathic pain in mice. Mol Pain (2014) 0.82

The Possible Role of Flavonoids in the Prevention of Diabetic Complications. Nutrients (2016) 0.81

High-Fat Diet-Induced Retinal Dysfunction. Invest Ophthalmol Vis Sci (2015) 0.79

Axon degeneration: make the Schwann cell great again. Neural Regen Res (2017) 0.76

Thrombospondin-4 divergently regulates voltage-gated Ca2+ channel subtypes in sensory neurons after nerve injury. Pain (2016) 0.76

The fundamental unit of pain is the cell. Pain (2013) 0.76

Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy. Sci Rep (2017) 0.75

TRP channels: potential drug target for neuropathic pain. Inflammopharmacology (2016) 0.75

Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain. Inflammopharmacology (2016) 0.75

Articles cited by this

(truncated to the top 100)

Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature (2000) 12.33

Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol (2003) 9.07

Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol (2004) 7.23

Neuronal calcium signaling. Neuron (1998) 7.03

The mitochondrial calcium uniporter is a highly selective ion channel. Nature (2004) 6.97

Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev (1999) 6.30

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA (1998) 5.91

Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci (2009) 5.53

Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol (2001) 4.43

Prevalence of chronic pain with neuropathic characteristics in the general population. Pain (2007) 3.72

Mitochondria and neuronal survival. Physiol Rev (2000) 3.56

Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev (2004) 2.83

Calcium microdomains: organization and function. Cell Calcium (2006) 2.81

Physiology and pathophysiology of the calcium store in the endoplasmic reticulum of neurons. Physiol Rev (2005) 2.77

Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron (2007) 2.70

Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med (2008) 2.44

Treatment of neuropathic pain: an overview of recent guidelines. Am J Med (2009) 2.43

Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain (2004) 2.34

Glucose neurotoxicity. Nat Rev Neurosci (2008) 2.32

Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci (2000) 2.23

Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J Biol Chem (2001) 2.19

High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J (2002) 2.18

Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J (2004) 2.15

Injury type-specific calcium channel alpha 2 delta-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther (2002) 2.12

Quantitation of epidermal nerves in diabetic neuropathy. Neurology (1996) 2.12

Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care (2002) 2.06

The diabetic foot: from art to science. The 18th Camillo Golgi lecture. Diabetologia (2004) 2.04

Lilly Lecture 1993. Glycation and diabetic complications. Diabetes (1994) 1.92

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90

Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium (2003) 1.79

The inositol 1,4,5-trisphosphate receptors. Cell Calcium (2005) 1.78

Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med (1994) 1.74

The increased trafficking of the calcium channel subunit alpha2delta-1 to presynaptic terminals in neuropathic pain is inhibited by the alpha2delta ligand pregabalin. J Neurosci (2009) 1.73

Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium (2005) 1.73

The economic cost of diabetes in Canada, 1998. Diabetes Care (2002) 1.71

Cell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neurons. J Neurosci (2007) 1.69

Intraluminal calcium as a primary regulator of endoplasmic reticulum function. Cell Calcium (2005) 1.68

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med (2004) 1.65

Calcium and mitochondria. FEBS Lett (2004) 1.64

Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia (2005) 1.64

Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using omega-conotoxin from Conus magus venom. Biochemistry (1987) 1.60

Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci (1998) 1.59

Diminished expression of sarcoplasmic reticulum Ca(2+)-ATPase and ryanodine sensitive Ca(2+)Channel mRNA in streptozotocin-induced diabetic rat heart. J Mol Cell Cardiol (2000) 1.57

Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain (1999) 1.54

Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci (2001) 1.54

Polyol pathway and diabetic peripheral neuropathy. Int Rev Neurobiol (2002) 1.53

Evidence that mitochondria buffer physiological Ca2+ loads in lizard motor nerve terminals. J Physiol (1998) 1.52

Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes (2003) 1.50

Calcium ions and integration in neural circuits. Acta Physiol (Oxf) (2006) 1.47

Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain (2003) 1.46

Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes (2000) 1.45

Modulating sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium (2005) 1.43

Cost of managing complications resulting from type 2 diabetes mellitus in Canada. BMC Health Serv Res (2003) 1.42

Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg (2006) 1.40

The effects of nerve growth factor and its antiserum on synapses in the superior cervical ganglion of the guinea-pig. J Physiol (1978) 1.40

Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia (2006) 1.35

Calcium signalling: past, present and future. Cell Calcium (2005) 1.31

Direct insulin signaling of neurons reverses diabetic neuropathy. Diabetes (2004) 1.30

Mitochondria as biosensors of calcium microdomains. Cell Calcium (1999) 1.30

Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. NeuroRx (2005) 1.29

In vivo silencing of the Ca(V)3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy. Pain (2009) 1.28

Activation of mu opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current. Neuron (1991) 1.28

Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat. Pain (2004) 1.28

Neuropathic pain: emerging treatments. Br J Anaesth (2008) 1.28

Caffeine-induced calcium release from internal stores in cultured rat sensory neurons. Neuroscience (1993) 1.27

Ca(2+) dynamics in the lumen of the endoplasmic reticulum in sensory neurons: direct visualization of Ca(2+)-induced Ca(2+) release triggered by physiological Ca(2+) entry. EMBO J (2002) 1.27

Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? Diabetes (2005) 1.25

Ryanodine receptor-mediated intracellular calcium release in rat cerebellar Purkinje neurones. J Physiol (1995) 1.23

Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes (2009) 1.22

Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG. Mol Cell Neurosci (2007) 1.21

Cyclic Ca2+ changes in intracellular stores of gonadotropes during gonadotropin-releasing hormone-stimulated Ca2+ oscillations. Proc Natl Acad Sci U S A (1994) 1.20

Stimulation-evoked increases in cytosolic [Ca(2+)] in mouse motor nerve terminals are limited by mitochondrial uptake and are temperature-dependent. J Neurosci (2000) 1.19

Ryanodine receptors. Cell Calcium (2005) 1.18

T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J Neurosci (2009) 1.18

Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options. Int Rev Neurobiol (2002) 1.18

Mitochondrial malfunction and Ca2+ dyshomeostasis drive neuronal pathology in diabetes. Cell Calcium (2008) 1.17

Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol Cell Neurosci (2005) 1.15

Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain (1995) 1.15

Regulation of neuronal T-type calcium channels. Trends Pharmacol Sci (2008) 1.14

Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Brain Res Rev (1995) 1.14

Monitoring of free calcium in the neuronal endoplasmic reticulum: an overview of modern approaches. J Neurosci Methods (2002) 1.13

Ca2+-induced Ca2+ release in chromaffin cells seen from inside the ER with targeted aequorin. J Cell Biol (1999) 1.12

Calcium channels as therapeutic targets in neuropathic pain. J Pain (2006) 1.11

Diabetes-induced alterations in calcium homeostasis in sensory neurones of streptozotocin-diabetic rats are restricted to lumbar ganglia and are prevented by neurotrophin-3. Diabetologia (2002) 1.10

Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling. Glia (2008) 1.09

The endoplasmic reticulum as an integrating signalling organelle: from neuronal signalling to neuronal death. Eur J Pharmacol (2002) 1.09

Retracted Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes (2009) 1.09

Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats. Am J Physiol Endocrinol Metab (2005) 1.09

The endoplasmic reticulum and neuronal calcium signalling. Cell Calcium (2003) 1.08

Measuring [Ca2+] in the endoplasmic reticulum with aequorin. Cell Calcium (2003) 1.08

NAADP receptors. Cell Calcium (2005) 1.07

Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy. Acta Neuropathol (1998) 1.06

Growth factors as therapeutics for diabetic neuropathy. Curr Drug Targets (2008) 1.04

Diabetes-induced abnormalities in ER calcium mobilization in primary and secondary nociceptive neurons. Pflugers Arch (2004) 1.04

Neurotrophin-3 prevents mitochondrial dysfunction in sensory neurons of streptozotocin-diabetic rats. Exp Neurol (2005) 1.03

Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy. J Peripher Nerv Syst (2003) 1.02

Transgenic overexpression of the sarcoplasmic reticulum Ca2+ATPase improves reticular Ca2+ handling in normal and diabetic rat hearts. FASEB J (2002) 1.02

Endoplasmic reticulum Ca(2+) homeostasis and neuronal death. J Cell Mol Med (2004) 1.01

Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol (1997) 1.01

Articles by these authors

Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem (2003) 2.42

Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes (2003) 1.50

NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth. J Cell Biol (2003) 1.41

Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain (2004) 1.40

Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice. Neurosci Lett (2008) 1.31

Epidermal nerve fiber quantification in the assessment of diabetic neuropathy. Acta Histochem (2008) 1.29

Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction. Diabetes Metab Res Rev (2010) 1.21

Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters. Pain (2008) 1.18

Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes (2010) 1.17

The roles of streptozotocin neurotoxicity and neutral endopeptidase in murine experimental diabetic neuropathy. Exp Diabetes Res (2010) 1.13

Gene replacement in mice reveals that the heavily phosphorylated tail of neurofilament heavy subunit does not affect axonal caliber or the transit of cargoes in slow axonal transport. J Cell Biol (2002) 1.11

Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain (2012) 1.10

Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulin. J Peripher Nerv Syst (2013) 1.04

Phosphorylation of highly conserved neurofilament medium KSP repeats is not required for myelin-dependent radial axonal growth. J Neurosci (2009) 1.04

Pathogenesis of spinally mediated hyperalgesia in diabetes. Diabetes (2007) 1.03

The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiol Aging (2008) 1.01

Ciliary neurotrophic factor improves nerve conduction and ameliorates regeneration deficits in diabetic rats. Diabetes (2004) 0.99

Mitochondrion as a novel site of dichloroacetate biotransformation by glutathione transferase zeta 1. J Pharmacol Exp Ther (2010) 0.98

B vitamins alleviate indices of neuropathic pain in diabetic rats. Eur J Pharmacol (2009) 0.95

Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats. Brain Res (2006) 0.89

Muscle pathology without severe nerve pathology in a new mouse model of Charcot-Marie-Tooth disease type 2E. Hum Mol Genet (2011) 0.88

Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes (2002) 0.87

Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents. Neuropharmacology (2012) 0.87

Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats. Diabetes (2003) 0.86

Animal models of diabetes-induced neuropathic pain. Curr Top Behav Neurosci (2014) 0.85

MALDI-linear ion trap microprobe MS/MS studies of the effects of dichloroacetate on lipid content of nerve tissue. Anal Chem (2007) 0.84

Considerations for quantification of lipids in nerve tissue using matrix-assisted laser desorption/ionization mass spectrometric imaging. Rapid Commun Mass Spectrom (2011) 0.84

Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats. Acta Neuropathol (2012) 0.83

Ciliary neurotrophic factor reverses aberrant mitochondrial bioenergetics through the JAK/STAT pathway in cultured sensory neurons derived from streptozotocin-induced diabetic rodents. Cell Mol Neurobiol (2014) 0.82

Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia. Pain (2006) 0.82

Novel sites of aldose reductase immunolocalization in normal and streptozotocin-diabetic rats. J Peripher Nerv Syst (2006) 0.82

Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRα/RET receptor signaling. Proc Natl Acad Sci U S A (2014) 0.82

The α5 subunit containing GABAA receptors contribute to chronic pain. Pain (2016) 0.80

Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide. J Neuropathol Exp Neurol (2008) 0.79

Expansion of neurofilament medium C terminus increases axonal diameter independent of increases in conduction velocity or myelin thickness. J Neurosci (2012) 0.78

Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism (2008) 0.78

Guaifenesin derivatives promote neurite outgrowth and protect diabetic mice from neuropathy. J Med Chem (2013) 0.77

Functional magnetic resonance imaging of the spinal cord during sensory stimulation in diabetic rats. J Magn Reson Imaging (2009) 0.77

Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. J Clin Invest (2017) 0.75

Central action of prosaptide TX14(A) against gp120-induced allodynia in rats. Eur J Pain (2007) 0.75